Loading company…
Sleepisol develops a platform for diagnosing and treating brain diseases.
Sleepisol develops healthcare technology for the diagnosis and treatment of brain diseases. Founded in 2017, the company is based in Seoul, South Korea. In February 2026, it raised KRW 3 billion in series A funding led by BNK Venture Capital, part of a larger KRW 7 billion series A funding. It plans to support device development and AI-based mental health platforms.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in